Literature DB >> 10521303

Hypomethylation of an expanded FMR1 allele is not associated with a global DNA methylation defect.

R W Burman1, P A Yates, L D Green, P B Jacky, M S Turker, B W Popovich.   

Abstract

The vast majority of fragile-X full mutations are heavily methylated throughout the expanded CGG repeat and the surrounding CpG island. Hypermethylation initiates and/or stabilizes transcriptional inactivation of the FMR1 gene, which causes the fragile X-syndrome phenotype characterized, primarily, by mental retardation. The relation between repeat expansion and hypermethylation is not well understood nor is it absolute, as demonstrated by the identification of nonretarded males who carry hypomethylated full mutations. To better characterize the methylation pattern in a patient who carries a hypomethylated full mutation of approximately 60-700 repeats, we have evaluated methylation with the McrBC endonuclease, which allows analysis of numerous sites in the FMR1 CpG island, including those located within the CGG repeat. We report that the expanded-repeat region is completely free of methylation in this full-mutation male. Significantly, this lack of methylation appears to be specific to the expanded FMR1 CGG-repeat region, because various linked and unlinked repetitive-element loci are methylated normally. This finding demonstrates that the lack of methylation in the expanded CGG-repeat region is not associated with a global defect in methylation of highly repeated DNA sequences. We also report that de novo methylation of the expanded CGG-repeat region does not occur when it is moved via microcell-mediated chromosome transfer into a de novo methylation-competent mouse embryonal carcinoma cell line.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521303      PMCID: PMC1288290          DOI: 10.1086/302628

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  73 in total

1.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome.

Authors:  I Oberlé; F Rousseau; D Heitz; C Kretz; D Devys; A Hanauer; J Boué; M F Bertheas; J L Mandel
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

2.  A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases.

Authors:  F Rousseau; D Heitz; J Tarleton; J MacPherson; H Malmgren; N Dahl; A Barnicoat; C Mathew; E Mornet; I Tejada
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

3.  The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation.

Authors:  D Devys; Y Lutz; N Rouyer; J P Bellocq; J L Mandel
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

4.  Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome.

Authors:  A McConkie-Rosell; A M Lachiewicz; G A Spiridigliozzi; J Tarleton; S Schoenwald; M C Phelan; P Goonewardena; X Ding; W T Brown
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

5.  Genotype-phenotype relationships in fragile X syndrome: a family study.

Authors:  D Z Loesch; R Huggins; D A Hay; A K Gedeon; J C Mulley; G R Sutherland
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

6.  DNA methylation of the fragile X locus in somatic and germ cells during fetal development: relevance to the fragile X syndrome and X inactivation.

Authors:  S Luo; J C Robinson; A L Reiss; B R Migeon
Journal:  Somat Cell Mol Genet       Date:  1993-07

7.  High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression.

Authors:  R J Hagerman; C E Hull; J F Safanda; I Carpenter; L W Staley; R A O'Connor; C Seydel; M M Mazzocco; K Snow; S N Thibodeau
Journal:  Am J Med Genet       Date:  1994-07-15

Review 8.  Unstable triplets and their mutational mechanism: size reduction of the CGG repeat vs. germline mosaicism in the fragile X syndrome.

Authors:  P Chiurazzi; L Kozak; G Neri
Journal:  Am J Med Genet       Date:  1994-07-15

9.  High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome.

Authors:  I K Hornstra; D L Nelson; S T Warren; T P Yang
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

10.  Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population.

Authors:  K Snow; L K Doud; R Hagerman; R G Pergolizzi; S H Erster; S N Thibodeau
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

View more
  7 in total

Review 1.  GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.

Authors:  S Hossein Fatemi; Timothy D Folsom
Journal:  Schizophr Res       Date:  2014-11-26       Impact factor: 4.939

2.  The development and validation of EpiComet-Chip, a modified high-throughput comet assay for the assessment of DNA methylation status.

Authors:  Todd A Townsend; Marcus C Parrish; Bevin P Engelward; Mugimane G Manjanatha
Journal:  Environ Mol Mutagen       Date:  2017-07-29       Impact factor: 3.216

3.  Disease-Associated Short Tandem Repeats Co-localize with Chromatin Domain Boundaries.

Authors:  James H Sun; Linda Zhou; Daniel J Emerson; Sai A Phyo; Katelyn R Titus; Wanfeng Gong; Thomas G Gilgenast; Jonathan A Beagan; Beverly L Davidson; Flora Tassone; Jennifer E Phillips-Cremins
Journal:  Cell       Date:  2018-08-30       Impact factor: 41.582

4.  Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?

Authors:  U Salat; B Bardoni; D Wöhrle; P Steinbach
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

5.  Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.

Authors:  Roberta Pietrobono; Maria Grazia Pomponi; Elisabetta Tabolacci; Ben Oostra; Pietro Chiurazzi; Giovanni Neri
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

6.  The structure of the Thermococcus gammatolerans McrB N-terminal domain reveals a new mode of substrate recognition and specificity among McrB homologs.

Authors:  Christopher J Hosford; Anthony Q Bui; Joshua S Chappie
Journal:  J Biol Chem       Date:  2019-12-10       Impact factor: 5.157

7.  Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells.

Authors:  Achia Urbach; Ori Bar-Nur; George Q Daley; Nissim Benvenisty
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.